Investing.com -- Novo Nordisk is preparing for a "full-fledged" launch of oral semaglutide in the United States in early 2026, according to the company’s head of product and portfolio strategy.

FactSet’s revenue growth is fueled by the expansion of its recurring revenue base, innovation in the generative AI sector, ...

With expense ratios of 0.03% to 0.13%, these exchange-traded funds offer diverse market exposure with less fee-driven drag on your returns.

It marks the biggest raising from an ASX-listed fund in 2025, and is followed by Revolution Asset Management’s Private Income ...

It’s part of a broader strategy by San Antonio’s municipally-owned utility to acquire relatively new plants instead of ...

Statements of advice are a key part of the financial planning process, but some are much better than others. Here is what to ...

Parliament’s Portfolio Committee on Correctional Services has raised concerns over the number of unnatural deaths occurring ...

The commissioners went against the recommendations of the agency, which manages a $2.9 billion investment portfolio. Earnings from the investments provided more than $156 million for education in ...

Temple Lifestyle offers diversified manufacturing capabilities, a broad omnichannel distribution network, and a strong commercial engine.

IMD has also highlighted a flash flood risk in certain watersheds and neighbourhoods in UP and Bihar over the next 24 hours, ...

Before investing in any 721 UPREIT exchange, look for one that offers a straightforward, investor-friendly exit.

Unlike many of the recent market launches focused on cryptocurrency treasury assets, Figure aims to utilize blockchain to ...